Clinical Trials List
Protocol NumberC5751001/SGNB6A-001
Active
2024-06-01 - 2028-10-22
Phase I
Recruiting3
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Shih-Feng Cho 無
- Yi-Chang Liu 無
- 王閔宏 無
- 高育青 無
- Hui-Hua Hsiao 無
- Chih-Jen Yang 無
- 蘇勇曄 無
- Jeng-Shiun Du 無
- Tsung-Jang Yeh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭弘揚 無
- 徐偉勛 無
- JHE-CYUAN GUO 無
- Hsiang-Fong Kao 無
- TA-CHEN HUANG 無
- Chia-Chi Lin 無
- 莊建淮 無
- HUAI-CHENG HUANG 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
824 participants
